Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Moolec Science ( (MLEC) ) just unveiled an update.
On May 13, 2026, Moolec Science SA filed a Form 6-K with the U.S. Securities and Exchange Commission for the month of May 2026, incorporating by reference unaudited interim condensed consolidated financial statements. The filing covers the company’s financial position as of December 31, 2025 and June 30, 2025, and its results for the six-month periods ended December 31, 2025 and 2024, showing the transition from significant operating losses to a reported profit largely driven by a gain on deconsolidation of a subsidiary and discontinued operations.
The interim statements reveal that Moolec generated $5.23 million in revenue from contracts with customers in the six months to December 31, 2025, versus no such revenue a year earlier, while still posting an operating loss of $6.2 million from continuing operations. After recognizing a $129.3 million gain on the deconsolidation of a subsidiary and profits from discontinued operations, the group reported net profit of $92.0 million and total comprehensive income of $94.2 million, marking a sharp turnaround from a $36.8 million net loss and $38.3 million comprehensive loss in the prior-year period and signaling a major shift in its structure and financial profile for investors and other stakeholders.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.
The score is held down primarily by weak financial health—large losses, continued cash burn, and a materially weakened capital structure with negative equity and elevated debt. Technicals are moderately supportive with improving intermediate momentum, but valuation remains constrained by unprofitability and no dividend support.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science SA is a foreign private issuer listed in the United States and domiciled in the Cayman Islands. The company files its reports with the U.S. Securities and Exchange Commission under Form 20-F, reflecting its status as an international issuer accessing U.S. capital markets.
Average Trading Volume: 478,492
Technical Sentiment Signal: Sell
Current Market Cap: $6.38M
Learn more about MLEC stock on TipRanks’ Stock Analysis page.